Michal Masařík, Ph.D.

Publications that are part of the Web of Science database, possibly also other publications chosen by authors.

2021

• ŠTĚPKA, P.; VŠIANSKÝ, V.; RAUDENSKÁ, M.; GUMULEC, J.; ADAM, V.; MASAŘÍK, M., 2021: Metabolic and amino acid alterations of the tumor microenvironment. CURRENT MEDICINAL CHEMISTRY , p. 1270 - 20, doi: 10.2174/0929867327666200207114658; FULL TEXT
• VLČNOVSKÁ, M.; ŠTOSSOVÁ, A.; KUCHYNKA, M.; DILLINGEROVÁ, V.; POLANSKÁ, H.; MASAŘÍK, M.; HRSTKA, R.; ADAM, V.; KANICKÝ, V.; VACULOVIČ, T.; VACULOVIČOVÁ, M., 2021: Comparison of metal nanoparticles (Au, Ag, Eu, Cd) used for immunoanalysis using LA-ICP-MS detection. MOLECULES , p. 246 - 14, doi: 10.3390/molecules26030630; FULL TEXT

2020

• FOJTŮ, M.; BALVAN, J.; RAUDENSKÁ, M.; VIČAR, T.; ŠTURALA, J.; SOFER, Z.; LUXA, J.; PLUTNAR, J.; MASAŘÍK, M.; PUMERA, M., 2020: 2D Germanane Derivative as a Vector for Overcoming Doxorubicin Resistance in Cancer Cells. APPLIED MATERIALS TODAY , p. 100697-1 - 14, doi: 10.1016/j.apmt.2020.100697; FULL TEXT
• VLČNOVSKÁ, M.; ŠTOSSOVÁ, A.; TVRDOŇOVÁ, M.; POLANSKÁ, H.; VACULOVIČOVÁ, M.; VACULOVIČ, T.; MASAŘÍK, M., 2020: Nanoparticles as a biorecognition platform in combination with LA-ICP-MS. , p. 434 - 4, doi: 10.37904/nanocon.2019.8632; FULL TEXT

2019

• VŠIANSKÝ, V.; SVOBODOVÁ, M.; GUMULEC, J.; CERNEI, N.; ŠTĚRBOVÁ, D.; ZÍTKA, O.; KOSTŘICA, R.; SMILEK, P.; PLZÁK, J.; BETKA, J.; KALFERT, D.; MASAŘÍK, M.; RAUDENSKÁ, M., 2019: Prognostic Significance of Serum Free Amino Acids in Head and Neck Cancers. CELLS 8(5), p. 1 - 12, doi: 10.3390/cells8050428; FULL TEXT
• RAUDENSKÁ, M.; BALVAN, J.; FOJTŮ, M.; GUMULEC, J.; MASAŘÍK, M., 2019: Unexpected therapeutic effects of cisplatin. METALLOMICS 11(7), p. 1182 - 18, doi: 10.1039/c9mt00049f; FULL TEXT
• JIMENEZ JIMENEZ, A.; MOULICK, A.; BHOWMICK, S.; STRMISKA, V.; GAGIĆ, M.; HORÁKOVÁ, Z.; KOSTŘICA, R.; MASAŘÍK, M.; HEGER, Z.; ADAM, V., 2019: One-Step Detection of Human Papilloma Viral Infection Using Quantum Dot-Nucleotide Interaction Specificity. TALANTA 205, p. 1 - 8, doi: 10.1016/j.talanta.2019.07.006; FULL TEXT
• FOJTŮ, M.; BALVAN, J.; RAUDENSKÁ, M.; VIČAR, T.; BOUŠA, D.; SOFER, Z.; MASAŘÍK, M.; PUMERA, M., 2019: Black Phosphorus Cytotoxicity Assessments Pitfalls: Advantages and Disadvantages of Metabolic and Morphological Assays. CHEMISTRY-A EUROPEAN JOURNAL 25(1), p. 349 - 13, doi: 10.1002/chem.201804434; FULL TEXT
• RAUDENSKÁ, M.; KRATOCHVÍLOVÁ, M.; VIČAR, T.; GUMULEC, J.; BALVAN, J.; POLANSKÁ, H.; PŘIBYL, J.; MASAŘÍK, M., 2019: Cisplatin enhances cell stiffness and decreases invasiveness rate in prostate cancer cells by actin accumulation. SCIENTIFIC REPORTS 9, p. 1 - 11, doi: 10.1038/s41598-018-38199-7; FULL TEXT
• VIČAR, T.; BALVAN, J.; JAROŠ, J.; JUG, F.; KOLÁŘ, R.; MASAŘÍK, M.; GUMULEC, J., 2019: Cell segmentation methods for label-free contrast microscopy: review and comprehensive comparison. BMC BIOINFORMATICS 20, p. 1 - 25, doi: 10.1186/s12859-019-2880-8; FULL TEXT
• VLČNOVSKÁ, M.; TVRDOŇOVÁ, M.; ŠTOSSOVÁ, A.; POLANSKÁ, H.; VACULOVIČOVÁ, M.; VACULOVIČ, T.; MASAŘÍK, M., 2019: LA-ICP-MS as a tool for protein detection. , p. 52 - 1; FULL TEXT
• VLČNOVSKÁ, M.; TVRDOŇOVÁ, M.; ŠTOSSOVÁ, A.; POLANSKÁ, H.; VACULOVIČOVÁ, M.; VACULOVIČ, T.; MASAŘÍK, M., 2019: LA-ICP-MS as a sensitive method for detection of nanoparticle-antibody conjugates in immunochemistry analysis. , p. 682 - 5; FULL TEXT

2018

• GUMULEC, J.; RAUDENSKÁ, M.; KRATOCHVÍLOVÁ, M.; PŘIBYL, J.; VIČAR, T.; MASAŘÍK, M., 2018: Enhancement of cell stiffness and disorganization of cytoskeletal architecture upon cisplatin treatment in head and neck cancer cell model. , p. P1607 - 1; FULL TEXT
• DOSTÁLOVÁ, S.; POLANSKÁ, H.; SVOBODOVÁ, M.; BALVAN, J.; KRYŠTOFOVÁ, O.; HADDAD, Y.; KŘÍŽKOVÁ, S.; MASAŘÍK, M.; ECKSCHLAGER, T.; STIBOROVÁ, M.; HEGER, Z.; ADAM, V., 2018: Prostate-Specific Membrane Antigen-Targeted Site-Directed Antibody-Conjugated Apoferritin Nanovehicle Favorably Influences In Vivo Side Effects of Doxorubicin. SCIENTIFIC REPORTS 8, p. 1 - 13, doi: 10.1038/s41598-018-26772-z; FULL TEXT
• JIMENEZ JIMENEZ, A.; MOULICK, A.; RICHTERA, L.; KREJČOVÁ, L.; KALINA, L.; DATTA, R.; SVOBODOVÁ, M.; HYNEK, D.; MASAŘÍK, M.; HEGER, Z.; ADAM, V., 2018: Dual-color quantum dots-based simultaneous detection of HPV-HIV co-infection. SENSORS AND ACTUATORS B: CHEMICAL 258, p. 295 - 9, doi: 10.1016/j.snb.2017.11.074; FULL TEXT

2017

• Fojtu, M; Chia, X; Sofer, Z; Masarik, M; Pumera, M, 2017: Black Phosphorus Nanoparticles Potentiate the Anticancer Effect of Oxaliplatin in Ovarian Cancer Cell Line. ADV. FUNCT. MATER.
• KRATOCHVÍLOVÁ, M.; RAUDENSKÁ, M.; HEGER, Z.; RICHTERA, L.; CERNEI, N.; ADAM, V.; BABULA, P.; NOVÁKOVÁ, M.; MASAŘÍK, M.; GUMULEC, J., 2017: Amino Acid Profiling of Zinc Resistant Prostate Cancer Cell Lines: Associations With Cancer Progression. PROSTATE 77(6), p. 604 - 13, doi: 10.1002/pros.23304; FULL TEXT
• HEGER, Z.; POLANSKÁ, H.; KŘÍŽKOVÁ, S.; BALVAN, J.; RAUDENSKÁ, M.; DOSTÁLOVÁ, S.; MOULICK, A.; MASAŘÍK, M.; ADAM, V., 2017: Co-delivery of VP-16 and Bcl-2-targeted antisense on PEG-grafted oMWCNTs for synergistic in vitro anti-cancer effects in non-small and small cell lung cancer. COLLOIDS AND SURFACES B: BIOINTERFACES 150, p. 131 - 10, doi: 10.1016/j.colsurfb.2016.11.023; FULL TEXT
• DOSTÁLOVÁ, S.; POLANSKÁ, H.; SVOBODOVÁ, M.; BALVAN, J.; KRYŠTOFOVÁ, O.; MASAŘÍK, M.; ECKSCHLAGER, T.; STIBOROVÁ, M.; HEGER, Z.; ADAM, V., 2017: In vivo biocompatibility of site-directed apoferritin-based nanocarrier for cardiotoxic antitumour drug doxorubicin. , p. 168 - 2
• DOSTÁLOVÁ, S.; POLANSKÁ, H.; SVOBODOVÁ, M.; BALVAN, J.; KRYŠTOFOVÁ, O.; MASAŘÍK, M.; ECKSCHLAGER, T.; STIBOROVÁ, M.; HEGER, Z.; ADAM, V., 2017: In vivo biocompatibility of site-directed apoferritin-based nanocarrier for cardiotoxic antitumour drug doxorubicin. , p. 168 - 2; FULL TEXT
• GUMULEC, J.; RAUDENSKÁ, M.; KRATOCHVÍLOVÁ, M.; PŘIBYL, J.; PELTANOVÁ, B.; VIČAR, T.; MASAŘÍK, M., 2017: Association of cell stiffness and migratory potential of head and neck and prostate cancer cells exposed to cytostatics. . , p. P3001 - 1; FULL TEXT
• KOMÍNKOVÁ, M.; MILOSAVLJEVIĆ, V.; VÍTEK, P.; POLANSKÁ, H.; ČÍHALOVÁ, K.; DOSTÁLOVÁ, S.; HYNŠTOVÁ, V.; GURÁŇ, R.; KOPEL, P.; RICHTERA, L.; MASAŘÍK, M.; BRTNICKÝ, M.; KYNICKÝ, J.; ZÍTKA, O.; ADAM, V., 2017: Comparative study on toxicity of extracellularly biosynthesized and laboratory synthesized CdTe quantum dots. JOURNAL OF BIOTECHNOLOGY 241, p. 193 - 8, doi: 10.1016/j.jbiotec.2016.10.024; FULL TEXT
• FOJTŮ, M.; GUMULEC, J.; STRAČINA, T.; RAUDENSKÁ, M.; SKOTÁKOVÁ, A.; VACULOVIČOVÁ, M.; ADAM, V.; BABULA, P.; NOVÁKOVÁ, M.; MASAŘÍK, M., 2017: Reduction of doxorubicin-induced cardiotoxicity using nanocarriers: A review. CURRENT DRUG METABOLISM 18(3), p. 237 - 27, doi: 10.2174/1389200218666170105165444; FULL TEXT
• SVOBODOVÁ, M.; RAUDENSKÁ, M.; GUMULEC, J.; BALVAN, J.; FOJTŮ, M.; KRATOCHVÍLOVÁ, M.; POLANSKÁ, H.; HORÁKOVÁ, Z.; KOSTŘICA, R.; BABULA, P.; HEGER, Z.; MASAŘÍK, M., 2017: Establishment of oral squamous cell carcinoma cell line and magnetic bead-based isolation and characterization of its CD90/CD44 subpopulations. ONCOTARGET 8(39), p. 66254 - 16, doi: 10.18632/oncotarget.19914; FULL TEXT
• RAUDENSKÁ, M.; DVOŘÁKOVÁ, V.; PÁCAL, L.; CHALÁSOVÁ, K.; KRATOCHVÍLOVÁ, M.; GUMULEC, J.; RUTTKAY-NEDECKÝ, B.; ZÍTKA, O.; KAŇKOVÁ, K.; ADAM, V.; MASAŘÍK, M., 2017: Levels of heavy metals and their binding protein metallothionein in type 2 diabetics with kidney disease. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY 31(6), p. 1 - 5, doi: 10.1002/jbt.21891; FULL TEXT
• RAUDENSKÁ, M.; KREJČOVÁ, L.; RICHTERA, L.; HEGER, Z.; HRABĚTA, J.; ECKSCHLAGER, T.; STIBOROVÁ, M.; ADAM, V.; KRATOCHVÍLOVÁ, M.; MASAŘÍK, M.; GUMULEC, J., 2017: VPA does not enhance platinum binding to DNA in cisplatin-resistant neuroblastoma cancer cells. TUMOR BIOLOGY 39(9), p. 1 - 8, doi: 10.1177/1010428317711656; FULL TEXT

2016

• HEGER, Z.; MERLOS RODRIGO, M.; MICHÁLEK, P.; POLANSKÁ, H.; MASAŘÍK, M.; VÍT, V.; PLEVOVÁ, M.; PACÍK, D.; ECKSCHLAGER, T.; STIBOROVÁ, M.; ADAM, V., 2016: Sarcosine up-regulates expression of genes involved in cell cycle progression of metastatic models of prostate cancer. PLOS ONE 11(11), p. 1 - 20, doi: 10.1371/journal.pone.0165830; FULL TEXT
• DOSTÁLOVÁ, S.; HEGER, Z.; POLANSKÁ, H.; MERLOS RODRIGO, M.; GURÁŇ, R.; KULICH, P.; KOPEL, P.; MASAŘÍK, M.; ECKSCHLAGER, T.; STIBOROVÁ, M.; KIZEK, R.; ADAM, V., 2016: Flotate receptor-targeted liposomes with encapsulated anti-sarcosine antibodies for attenuation of prostate tumors. EUROPEAN & GLOBAL SUMMIT FOR CLINICAL NANOMEDICINE AND TARGETED MEDICINE , p. 201 - 2; FULL TEXT
• HEGER, Z.; GUMULEC, J.; CERNEI, N.; POLANSKÁ, H.; RAUDENSKÁ, M.; MASAŘÍK, M.; ECKSCHLAGER, T.; STIBOROVÁ, M.; ADAM, V.; KIZEK, R., 2016: Relation of Exposure to Amino Acids Involved in Sarcosine Metabolic Pathway on Behavior of Non-Tumor and Malignant Prostatic Cell Lines. PROSTATE 76(7), p. 679 - 12, doi: 10.1002/pros.23159; FULL TEXT
• NGUYEN, H.; RICHTERA, L.; MOULICK, A.; XHAXHIU, K.; KUDR, J.; CERNEI, N.; POLANSKÁ, H.; HEGER, Z.; MASAŘÍK, M.; KOPEL, P.; STIBOROVÁ, M.; ECKSCHLAGER, T.; ADAM, V.; KIZEK, R., 2016: Electrochemical sensing of etoposide using carbon quantum dot modified glassy carbon electrode. ANALYST 141(9), p. 2665 - 11, doi: 10.1039/c5an02476e; FULL TEXT
• VEČEŘOVÁ, A.; HUDCOVÁ, K.; PILAŘOVÁ, I.; MASAŘÍK, M.; TRNKOVÁ, L., 2016: Electrochemical and spectral behaviour of miR-34a-5p. MONATSHEFTE FUER CHEMIE 147(1), p. 105 - 6, doi: 10.1007/s00706-015-1600-y; FULL TEXT
• SKALIČKOVÁ, S.; NEJDL, L.; KUDR, J.; RUTTKAY-NEDECKÝ, B.; JIMENEZ JIMENEZ, A.; KOPEL, P.; KREMPLOVÁ, M.; MASAŘÍK, M.; STIBOROVÁ, M.; ECKSCHLAGER, T.; ADAM, V.; KIZEK, R., 2016: Fluorescence Characterization of Gold Modified Liposomes with Antisense N-myc DNA Bound to the Magnetisable Particles with Encapsulated Anticancer Drugs (Doxorubicin, Ellipticine and Etoposide). SENSORS 16(3), p. 1 - 11, doi: 10.3390/s16030290; FULL TEXT
• HEGER, Z.; POLANSKÁ, H.; MERLOS RODRIGO, M.; GURÁŇ, R.; KULICH, P.; KOPEL, P.; MASAŘÍK, M.; ECKSCHLAGER, T.; STIBOROVÁ, M.; KIZEK, R.; ADAM, V., 2016: Prostate tumor attenuation in the nu/nu murine model due to antisarcosine antibodies in folate targeted liposomes. SCIENTIFIC REPORTS 6, p. 33379-1 - 11, doi: 10.1038/srep33379; FULL TEXT
• RESSNEROVÁ, A.; RAUDENSKÁ, M.; HOLUBOVÁ, M.; SVOBODOVÁ, M.; POLANSKÁ, H.; BABULA, P.; MASAŘÍK, M.; GUMULEC, J., 2016: Zinc and Copper Homeostasis in Head and Neck Cancer: Review and Meta-Analysis. CURRENT MEDICINAL CHEMISTRY 23(13), p. 1304 - 27, doi: 10.2174/0929867323666160405111543; FULL TEXT
• POLANSKÁ, H.; HEGER, Z.; GUMULEC, J.; RAUDENSKÁ, M.; SVOBODOVÁ, M.; BALVAN, J.; FOJTŮ, M.; BINKOVÁ, H.; HORÁKOVÁ, Z.; KOSTŘICA, R.; ADAM, V.; KIZEK, R.; MASAŘÍK, M., 2016: Effect of HPV on tumor expression levels of the most commonly used markers in HNSCC. TUMOR BIOLOGY 37(6), p. 7193 - 9, doi: 10.1007/s13277-015-4569-6; FULL TEXT
• POLANSKÁ, H.; RAUDENSKÁ, M.; HUDCOVÁ, K.; GUMULEC, J.; SVOBODOVÁ, M.; HEGER, Z.; FOJTŮ, M.; BINKOVÁ, H.; HORÁKOVÁ, Z.; KOSTŘICA, R.; ADAM, V.; KIZEK, R.; MASAŘÍK, M., 2016: Evaluation of EGFR as a prognostic and diagnostic marker for head and neck squamous cell carcinoma patients. ONCOLOGY LETTERS 12(3), p. 2127 - 6, doi: 10.3892/ol.2016.4896; FULL TEXT
• HUDCOVÁ, K.; RAUDENSKÁ, M.; GUMULEC, J.; BINKOVÁ, H.; HORÁKOVÁ, Z.; KOSTŘICA, R.; BABULA, P.; ADAM, V.; MASAŘÍK, M., 2016: Expression profiles of miR-29c, miR-200b and miR-375 in tumour and tumour-adjacent tissues of head and neck cancers . TUMOR BIOLOGY 37(9), p. 12627 - 7, doi: 10.1007/s13277-016-5147-2; FULL TEXT
• HEGER, Z.; GUMULEC, J.; ONDRÁK, A.; ŠKODA, J.; ZÍTKA, Z.; CERNEI, N.; MASAŘÍK, M.; ZÍTKA, O.; ADAM, V., 2016: Influence of Long-Distance Bicycle Riding on Serum/Urinary Biomarkers of Prostate Cancer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 17(3), p. 377-1 - 12, doi: 10.3390/ijms17030377; FULL TEXT
• STRMISKA, V.; MERLOS RODRIGO, M.; MICHÁLEK, P.; POLANSKÁ, H.; MASAŘÍK, M.; ADAM, V.; HEGER, Z., 2016: Sarcosine up-regulates expression of genes involved in cell cycle progression of metastatic models of prostate cancer. , p. 38 - 1; FULL TEXT

2015

• HOLUBOVÁ, M.; GUMULEC, J.; RAUDENSKÁ, M.; SZTALMACHOVÁ, M.; NOVÁKOVÁ, M.; KIZEK, R.; MASAŘÍK, M., 2015: The mechanisms of resistance in a prostate cancer model with long-term exposure to zinc. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 36, p. S34 - 1; FULL TEXT
• HUDCOVÁ, K.; RAUDENSKÁ, M.; POLANSKÁ, H.; GUMULEC, J.; FOJTŮ, M.; SZTALMACHOVÁ, M.; BALVAN, J.; BINKOVÁ, H.; HORÁKOVÁ, Z.; KOSTŘICA, R.; FEITH, M.; KIZEK, R.; MASAŘÍK, M., 2015: Expression profiling of selected miRNAs in connection with head and neck squamous cell carcinoma. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 36, p. S35 - 1; FULL TEXT
• FOJTŮ, M.; GUMULEC, J.; SZTALMACHOVÁ, M.; RAUDENSKÁ, M.; STRAČINA, T.; NOVÁKOVÁ, M.; KIZEK, R.; ADAM, V.; HLAVÁČOVÁ, M.; PAULOVÁ, H.; MASAŘÍK, M., 2015: Changes in oxidative stress status after the administration of doxorubicin-loaded nanocarriers. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 36, p. S34 - 1; FULL TEXT
• HEGER, Z.; CERNEI, N.; KŘÍŽKOVÁ, S.; MASAŘÍK, M.; KOPEL, P.; HODEK, P.; ZÍTKA, O.; ADAM, V.; KIZEK, R., 2015: Paramagnetic Nanoparticles as a Platform for FRET-Based Sarcosine Picomolar Detection. SCIENTIFIC REPORTS 5, p. 1 - 7, doi: 10.1038/srep08868; FULL TEXT
• BALVAN, J.; KŘÍŽOVÁ, A.; GUMULEC, J.; RAUDENSKÁ, M.; SLÁDEK, Z.; SEDLÁČKOVÁ, M.; BABULA, P.; SZTALMACHOVÁ, M.; KIZEK, R.; CHMELÍK, R.; MASAŘÍK, M., 2015: Multimodal Holographic Microscopy: Distinction between Apoptosis and Oncosis. PLOS ONE 10(3), p. 1 - 16, doi: 10.1371/journal.pone.0121674; FULL TEXT
• BALVAN, J.; GUMULEC, J.; RAUDENSKÁ, M.; KŘÍŽOVÁ, A.; ŠTĚPKA, P.; BABULA, P.; KIZEK, R.; ADAM, V.; MASAŘÍK, M., 2015: Oxidative Stress Resistance in Metastatic Prostate Cancer: Renewal by Self-Eating. PLOS ONE 10(12), p. 1 - 23, doi: 10.1371/journal.pone.0145016; FULL TEXT
• CHUDOBOVA, D.; ČÍHALOVÁ, K.; GURÁŇ, R.; DOSTÁLOVÁ, S.; ŠMERKOVÁ, K.; VESELÝ, R.; GUMULEC, J.; MASAŘÍK, M.; HEGER, Z.; ADAM, V.; KIZEK, R., 2015: Influence of microbiome species in hard-to-heal wounds on disease severity and treatment duration. BRAZ J INFECT DIS 19(6), p. 604 - 10, doi: 10.1016/j.bjid.2015.08.013; FULL TEXT
• RAUDENSKÁ, M.; SZTALMACHOVÁ, M.; GUMULEC, J.; FOJTŮ, M.; POLANSKÁ, H.; BALVAN, J.; FEITH, M.; BINKOVÁ, H.; HORÁKOVÁ, Z.; KOSTŘICA, R.; KÍZEK, R.; MASAŘÍK, M., 2015: Prognostic significance of the tumour-adjacent tissue in head and neck cancers. TUMOR BIOLOGY 36(12), p. 9929 - 11, doi: 10.1007/s13277-015-3755-x; FULL TEXT
• KŘÍŽOVÁ, A.; BALVAN, J.; GUMULEC, J.; SLABÝ, T.; MASAŘÍK, M.; CHMELÍK, R., 2015: Cell death type identification by quantitative phase imaging. MOLECULAR BIOLOGY OF THE CELL 26, p. P1553 - 1; FULL TEXT
• NEJDL, L.; NGUYEN, H.; RICHTERA, L.; KŘÍŽKOVÁ, S.; GURÁŇ, R.; MASAŘÍK, M.; HYNEK, D.; HEGER, Z.; LUNDBERG, K.; ERIKSON, K.; ADAM, V.; KÍZEK, R., 2015: Label-free bead-based metallothionein electrochemical immunosensor. ELECTROPHORESIS 36(16), p. 1894 - 11, doi: 10.1002/elps.201500069; FULL TEXT
• HUDCOVÁ, K.; TRNKOVÁ, L.; KEJNOVSKÁ, I.; VORLÍČKOVÁ, M.; GUMULEC, J.; KIZEK, R.; MASAŘÍK, M., 2015: Novel biophysical determination of miRNAs related to prostate and head and neck cancers. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS 44(3), p. 131 - 8, doi: 10.1007/s00249-015-1008-y; FULL TEXT
• HEGER, Z.; ZÍTKA, J.; CERNEI, N.; KŘÍŽKOVÁ, S.; SZTALMACHOVÁ, M.; KOPEL, P.; MASAŘÍK, M.; HODEK, P.; ZÍTKA, O.; ADAM, V.; KIZEK, R., 2015: 3D-printed biosensor with poly(dimethylsiloxane) reservoir for magnetic separation and quantum dots-based immunolabeling of metallothionein. ELECTROPHORESIS 36(42349), p. 1256 - 9, doi: 10.1002/elps.201400559; FULL TEXT
• HEGER, Z.; GUMULEC, J.; CERNEI, N.; TMEJOVÁ, K.; KOPEL, P.; BALVAN, J.; MASAŘÍK, M.; ZÍTKA, O.; BEKLOVÁ, M.; ADAM, V.; KIZEK, R., 2015: 17B-estradiol-containing liposomes as a novel delivery system for the antisense therapy of ER-positive breast cancer: An in vitro study on the MCF-7 cell line. ONCOLOGY REPORTS 33(2), p. 921 - 9, doi: 10.3892/or.2014.3627; FULL TEXT
• SZTALMACHOVÁ, M.; GUMULEC, J.; RAUDENSKÁ, M.; POLANSKÁ, H.; HOLUBOVÁ, M.; BALVAN, J.; HUDCOVÁ, K.; KNOPFOVÁ, L.; KÍZEK, R.; ADAM, V.; BABULA, P.; MASAŘÍK, M., 2015: Molecular response of 4T1-induced mouse mammary tumours and healthy tissues to zinc treatment. INTERNATIONAL JOURNAL OF ONCOLOGY 46(4), p. 1810 - 9, doi: 10.3892/ijo.2015.2883; FULL TEXT
• ŠMERKOVÁ, K.; HUDCOVÁ, K.; VLAHOVÁ, V.; VACULOVIČOVÁ, M.; PEKAŘÍK, V.; MASAŘÍK, M.; ADAM, V.; KÍZEK, R., 2015: Label-free and amplification-free miR-124 detection in human cells. INTERNATIONAL JOURNAL OF ONCOLOGY 46(2), p. 871 - 7, doi: 10.3892/ijo.2014.2756; FULL TEXT

2014

• HOLUBOVÁ, M.; AXMANOVÁ, M.; GUMULEC, J.; RAUDENSKÁ, M.; SZTALMACHOVÁ, M.; BABULA, P.; ADAM, V.; KIZEK, R.; MASAŘÍK, M., 2014: KRAS NF-jB is involved in the development of zinc resistance and reduced curability in prostate cancer. METALLOMICS 6(7), p. 1240 - 14, doi: 10.1039/c4mt00065j; FULL TEXT
• GUMULEC, J.; MASAŘÍK, M.; ADAM, V.; ECKSCHLAGER, T.; PROVAZNÍK, I.; KIZEK, R., 2014: Serum and Tissue Zinc in Epithelial Malignancies: A Meta-Analysis. PLOS ONE 9(6), p. 1 - 11, doi: 10.1371/journal.pone.0099790; FULL TEXT
• GUMULEC, J.; BALVAN, J.; SZTALMACHOVÁ, M.; RAUDENSKÁ, M.; TANHÄUSEROVÁ, V.; KNOPFOVÁ, L.; POLANSKÁ, H.; HUDCOVÁ, K.; RUTTKAY-NEDECKÝ, B.; BABULA, P.; ADAM, V.; KIZEK, R.; STIBOROVÁ, M.; MASAŘÍK, M., 2014: Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle. INTERNATIONAL JOURNAL OF ONCOLOGY 44(3), p. 923 - 11, doi: 10.3892/ijo.2013.2223; FULL TEXT
• POLANSKÁ, H.; RAUDENSKÁ, M.; GUMULEC, J.; SZTALMACHOVÁ, M.; ADAM, V.; KIZEK, R.; MASAŘÍK, M., 2014: Clinical significance of head and neck squamous cell cancer biomarkers. ORAL ONCOLOGY 50(3), p. 168 - 10, doi: 10.1016/j.oraloncology.2013.12.008; FULL TEXT
• FOJTŮ, M.; GUMULEC, J.; BALVAN, J.; RAUDENSKÁ, M.; SZTALMACHOVÁ, M.; POLANSKÁ, H.; ŠMERKOVÁ, K.; ADAM, V.; KIZEK, R.; MASAŘÍK, M., 2014: Utilization of paramagnetic microparticles for automated isolation of free circulating mRNA as a new tool in prostate cancer diagnostics. ELECTROPHORESIS 35(42065), p. 306 - 10, doi: 10.1002/elps.201300190; FULL TEXT
• Chudobova, D; Dostalova, S; Blazkova, I; Michalek, P; Ruttkay-Nedecky, B; Sklenar, M; Nejdl, L; Kudr, J; Gumulec, J; Tmejova, K; Konecna, M; Vaculovicova, M; Hynek, D; Masarik, M; Kynicky, J; Kizek, R; Adam, V, 2014: Effect of Ampicillin, Streptomycin, Penicillin and Tetracycline on Metal Resistant and Non-Resistant Staphylococcus aureus. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 11(3), p. 3233 - 3255, doi: 10.3390/ijerph110303233
• CHUDOBOVA, D.; ČÍHALOVÁ, K.; GURÁŇ, R.; DOSTÁLOVÁ, S.; ŠMERKOVÁ, K.; VESELÝ, R.; GUMULEC, J.; HEGER, Z.; MASAŘÍK, M.; ADAM, V.; KIZEK, R., 2014: IDENTIFICATION OF HUMAN MICROBIOME IN HARD-TO-HEAL WOUNDS BY MALDI-TOF MS AND SEQUENCING. CECE 2014: 11TH INTERNATIONAL INTERDISCIPLINARY MEETING ON BIOANALYSIS , p. 178 - 4; FULL TEXT
• GUMULEC, J.; FOJTŮ, M.; RAUDENSKÁ, M.; SZTALMACHOVÁ, M.; SKOTÁKOVÁ, A.; VLACHOVÁ, J.; SKALIČKOVÁ, S.; NEJDL, L.; KOPEL, P.; KNOPFOVÁ, L.; ADAM, V.; KIZEK, R.; STIBOROVÁ, M.; BABULA, P.; MASAŘÍK, M., 2014: Modulation of Induced Cytotoxicity of Doxorubicin by Using Apoferritin and Liposomal Cages. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 15(12), p. 22960 - 18, doi: 10.3390/ijms151222960; FULL TEXT
• HEGER, Z.; CERNEI, N.; GUMULEC, J.; MASAŘÍK, M.; ECKSCHLAGER, T.; HRABEC, R.; ZÍTKA, O.; ADAM, V.; KIZEK, R., 2014: Determination of common urine substances as an assay for improving prostate carcinoma diagnostics. ONCOLOGY REPORTS 31(4), p. 1846 - 9, doi: 10.3892/or.2014.3054; FULL TEXT
• RAUDENSKÁ, M.; GUMULEC, J.; PODLAHA, O.; SZTALMACHOVÁ, M.; BABULA, P.; ECKSCHLAGER, T.; ADAM, V.; KIZEK, R.; MASAŘÍK, M., 2014: Metallothionein polymorphisms in pathological processes. METALLOMICS 6(1), p. 55 - 14, doi: 10.1039/c3mt00132f; FULL TEXT
• GUMULEC, J.; RAUDENSKÁ, M.; ADAM, V.; KIZEK, R.; MASAŘÍK, M., 2014: Metallothionein – Immunohistochemical Cancer Biomarker: A Meta-Analysis. PLOS ONE 9(1), p. 1 - 14, doi: 10.1371/journal.pone.0085346; FULL TEXT
• HEGER, Z.; CERNEI, N.; BLAŽKOVÁ, I.; KOPEL, P.; MASAŘÍK, M.; ZÍTKA, O.; ADAM, V.; KIZEK, R., 2014: y-Fe2O3 Nanoparticles Covered with Glutathione-Modified Quantum Dots as a Fluorescent Nanotransporter. CHROMATOGRAPHIA 77(21-22), p. 1415 - 8, doi: 10.1007/s10337-014-2732-7; FULL TEXT
• MERLOS RODRIGO, M.; ZÍTKA, O.; KREJČOVÁ, L.; HYNEK, D.; MASAŘÍK, M.; KYNICKÝ, J.; HEGER, Z.; ADAM, V.; KIZEK, R., 2014: Electrochemical Microarray for Identification Pathogens: A Review. INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE 9(7), p. 3431 - 9; FULL TEXT

2013

• RAUDENSKÁ, M.; GUMULEC, J.; BABULA, P.; STRAČINA, T.; SZTALMACHOVÁ, M.; POLANSKÁ, H.; ADAM, V.; KIZEK, R.; NOVÁKOVÁ, M.; MASAŘÍK, M., 2013: Haloperidol Cytotoxicity and Its Relation to Oxidative Stress. MINI-REVIEWS IN MEDICINAL CHEMISTRY 13(14), p. 1993 - 6; FULL TEXT
• RUTTKAY-NEDECKÝ, B.; JIMENEZ JIMENEZ, A.; NEJDL, L.; CHUDOBOVÁ, D.; GUMULEC, J.; MASAŘÍK, M.; ADAM, V.; KIZEK, R., 2013: Relevance of infection with human papillomavirus: The role of the p53 tumor suppressor protein and E6/E7 zinc finger proteins. INTERNATIONAL JOURNAL OF ONCOLOGY 43(6), p. 1754 - 9, doi: 10.3892/ijo.2013.2105; FULL TEXT
• BABULA, P.; MASAŘÍK, M.; ADAM, V.; PROVAZNÍK, I.; KIZEK, R., 2013: From Na+/K+-ATPase and Cardiac Glycosides to Cytotoxicity and Cancer Treatment. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY 13(7), p. 1069 - 18; FULL TEXT
• CERNEI, N.; HEGER, Z.; GUMULEC, J.; ZÍTKA, O.; MASAŘÍK, M.; BABULA, P.; ECKSCHLAGER, T.; STIBOROVÁ, M.; KIZEK, R.; ADAM, V., 2013: Sarcosine as a potential prostate cancer biomarker – A review. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 14(7), p. 13893 - 15, doi: 10.3390/ijms140713893; FULL TEXT
• CERNEI, N.; ZÍTKA, O.; SKALIČKOVÁ, S.; GUMULEC, J.; SZTALMACHOVÁ, M.; MERLOS RODRIGO, M.; SOCHOR, J.; MASAŘÍK, M.; ADAM, V.; HUBÁLEK, J.; TRNKOVÁ, L.; KRUSEOVÁ, J.; ECKSCHLAGER, T.; KIZEK, R., 2013: Effect of sarcosine on antioxidant parameters and metallothionein content in the PC-3 prostate cancer cell line. ONCOLOGY REPORTS 29(6), p. 2459 - 8, doi: 10.3892/or.2013.2389; FULL TEXT
• GUMULEC, J.; RAUDENSKÁ, M.; HLAVNA, M.; STRAČINA, T.; SZTALMACHOVÁ, M.; TANHÄUSEROVÁ, V.; PÁCAL, L.; RUTTKAY-NEDECKÝ, B.; SOCHOR, J.; ZÍTKA, O.; BABULA, P.; ADAM, V.; KIZEK, R.; NOVÁKOVÁ, M.; MASAŘÍK, M., 2013: Determination of oxidative stress and activities of antioxidant enzymes in guinea pigs treated with haloperidol. EXPERIMENTAL AND THERAPEUTIC MEDICINE 5(2), p. 479 - 6, doi: 10.3892/etm.2012.822; FULL TEXT
• PEKAŘÍK, V.; GUMULEC, J.; MASAŘÍK, M.; KIZEK, R.; ADAM, V., 2013: Prostate cancer, miRNAs, metallothioneins and resistance to cytostatic drugs.. CURRENT MEDICINAL CHEMISTRY 20(4), p. 534 - 11; FULL TEXT
• GUMULEC, J.; SZTALMACHOVÁ, M.; POLANSKÁ, H.; HOLUBOVÁ, M.; BALVAN, J.; HUDCOVÁ, K.; BINKOVÁ, H.; HORÁKOVÁ, Z.; KOSTŘICA, R.; RAUDENSKÁ, M.; ZÍTKA, O.; ADAM, V.; KIZEK, R.; MASAŘÍK, M., 2013: Expression of Bcl-2 and other regulatory genes in primary cell culture derived from spinocellular tumour of head and neck. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 32, p. S47 - 1; FULL TEXT
• RUTTKAY-NEDECKÝ, B.; NEJDL, L.; GUMULEC, J.; ZÍTKA, O.; MASAŘÍK, M.; ECKSCHLAGER, T.; STIBOROVÁ, M.; ADAM, V.; KIZEK, R., 2013: The Role of Metallothionein in Oxidative Stress. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 14(3), p. 6044 - 23, doi: 10.3390/ijms14036044; FULL TEXT
• ZÍTKA, O.; KRYŠTOFOVÁ, O.; HYNEK, D.; ŠOBROVÁ, P.; KAISER, J.; SOCHOR, J.; ZEHNÁLEK, J.; BABULA, P.; FERROL, N.; KIZEK, R.; ADAM, V., 2013: Metal Transporters in Plants. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 32, p. 19 - 23; FULL TEXT
• ZÍTKA, O.; CERNEI, N.; HEGER, Z.; MATOUŠEK, M.; KOPEL, P.; KYNICKÝ, J.; MASAŘÍK, M.; KIZEK, R.; ADAM, V., 2013: Microfluidic chip coupled with modified paramagnetic particles for sarcosine isolation in urine. ELECTROPHORESIS 34(18), p. 2639 - 9, doi: 10.1002/elps.201300114; FULL TEXT

2012

• SOCHOR, J.; HYNEK, D.; KREJČOVÁ, L.; FABRIK, I.; KŘÍŽKOVÁ, S.; GUMULEC, J.; ADAM, V.; BABULA, P.; TRNKOVÁ, L.; STIBOROVÁ, M.; HUBÁLEK, J.; MASAŘÍK, M.; BINKOVÁ, H.; ECKSCHLAGER, T.; KIZEK, R., 2012: Study of Metallothionein Role in Spinocellular Carcinoma Tissues of Head and Neck Tumours using Brdicka Reaction. INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE 7(3), p. 2136 - 17; FULL TEXT
• GUMULEC, J.; SOCHOR, J.; HLAVNA, M.; SZTALMACHOVÁ, M.; KŘÍŽKOVÁ, S.; BABULA, P.; HRABEC, R.; ROVNÝ, A.; ADAM, V.; ECKSCHLAGER, T.; KIZEK, R.; MASAŘÍK, M., 2012: Caveolin-1 as a potential high-risk prostate cancer biomarker. ONCOLOGY REPORTS 27(3), p. 831 - 11, doi: 10.3892/or.2011.1587; FULL TEXT
• HYNEK, D.; KŘÍŽKOVÁ, S.; KREJČOVÁ, L.; GUMULEC, J.; VACULOVIČOVÁ, M.; CERNEI, N.; MASAŘÍK, M.; ADAM, V.; TRNKOVÁ, L.; STIBOROVÁ, M.; ECKSCHLAGER, T.; HUBÁLEK, J.; KIZEK, R., 2012: Femtogram electroanalytical detection of prostatic specific antigen by Brdicka reaction. INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE 7(3), p. 1749 - 18; FULL TEXT
• CHOMOUCKÁ, J.; DRBOHLAVOVÁ, J.; MASAŘÍK, M.; VACULOVIČOVÁ, M.; HÚSKA, D.; PRÁŠEK, J.; HORNA, A.; TRNKOVÁ, L.; PROVAZNÍK, I.; ADAM, V.; HUBÁLEK, J.; KIZEK, R., 2012: Nanotechnologies for society: new designs and applications of nanosensors and nanobiosensors in medicine and environmental analysis. INTERNATIONAL JOURNAL OF NANOTECHNOLOGY 9(42255), p. 746 - 38, doi: 10.1504/IJNT.2012.046752; FULL TEXT
• DOSTÁLOVÁ, S.; JÍLKOVÁ, E.; KŘÍŽKOVÁ, S.; MASAŘÍK, M.; ŠMERKOVÁ, K.; HYNEK, D.; RUTTKAY-NEDECKÝ, B.; KREJČOVÁ, L.; ADAM, V.; KIZEK, R., 2012: AUTOMATED ZINC PROTEINS EXTRACTION FROM PROSTATIC CANCER CELLS USING MAGNETIC PARTICLES. MENDELNET 2012 , p. 1174 - 9; FULL TEXT
• GUMULEC, J.; SZTALMACHOVÁ, M.; RAUDENSKÁ, M.; MASAŘÍK, M.; KIZEK, R., 2012: Revealing the role of zinc(II) in prostate cancer pathogenesis. , p. 934 - 8; FULL TEXT
• KREJČOVÁ, L.; FABRIK, I.; HYNEK, D.; KŘÍŽKOVÁ, S.; GUMULEC, J.; VACULOVIČOVÁ, M.; ADAM, V.; BABULA, P.; TRNKOVÁ, L.; STIBOROVÁ, M.; HUBÁLEK, J.; MASAŘÍK, M.; BINKOVÁ, H.; ECKSCHLAGER, T.; KIZEK, R., 2012: Metallothionein Electrochemically Determined using Brdicka Reaction as a Promising Blood Marker of Head and Neck Malignant Tumours. INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE 7(3), p. 1767 - 18; FULL TEXT
• MASAŘÍK, M.; GUMULEC, J.; HLAVNA, M.; SZTALMACHOVÁ, M.; BABULA, P.; RAUDENSKÁ, M.; PÁVKOVÁ GOLDBERGOVÁ, M.; CERNEI, N.; SOCHOR, J.; ZÍTKA, O.; RUTTKAY-NEDECKÝ, B.; KŘÍŽKOVÁ, S.; ADAM, V.; KIZEK, R., 2012: Monitoring of the prostate tumour cells redox state and real-time proliferation by novel biophysical techniques and fluorescent staining. INTEGRATIVE BIOLOGY 4(6), p. 672 - 13, doi: 10.1039/c2ib00157h; FULL TEXT
• CERNEI, N.; ZÍTKA, O.; VACULOVIČOVÁ, M.; ADAM, V.; MASAŘÍK, M.; HUBÁLEK, J.; KIZEK, R., 2012: Spectrometric and Electrochemical Analysis of Sarcosine as a Potential Prostate Carcinoma Marker. INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE 7(5), p. 4286 - 16; FULL TEXT
• POHANKA, M.; HYNEK, D.; KRACMAROVÁ, A.; KRUSEOVÁ, J.; RUTTKAY-NEDECKÝ, B.; SOCHOR, J.; ADAM, V.; HUBÁLEK, J.; MASAŘÍK, M.; ECKSCHLAGER, T.; KIZEK, R., 2012: Voltammetry Assay for Assessment of Oxidative Stress linked Pathologies in Brain Tumor suffered Childhood Patients. INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE 7(12), p. 11978 - 15; FULL TEXT
• HLAVNA, M.; RAUDENSKÁ, M.; HUDCOVÁ, K.; GUMULEC, J.; SZTALMACHOVÁ, M.; TANHÄUSEROVÁ, V.; BABULA, P.; ADAM, V.; ECKSCHLAGER, T.; KIZEK, R.; MASAŘÍK, M., 2012: MicroRNAs and zinc metabolism-related gene expression in prostate cancer cell lines treated with zinc(II) ions. INTERNATIONAL JOURNAL OF ONCOLOGY 41(6), p. 2237 - 8, doi: 10.3892/ijo.2012.1655; FULL TEXT
• JÍLKOVÁ, E.; KŘÍŽKOVÁ, S.; MASAŘÍK, M.; KENŠOVÁ, R.; ADAM, V.; KIZEK, R., 2012: PROFILE COMPARSION OF ZINC-PROTEINS IN CANCER AND CONTROL PROSTATIC CELLS EXPOSED A ZN(II). MENDELNET 2012 , p. 949 - 8; FULL TEXT
• SZTALMACHOVÁ, M.; GUMULEC, J.; CERNEI, N.; HLAVNA, M.; ZÍTKA, O.; BABULA, P.; ADAM, V.; KIZEK, R.; MASAŘÍK, M., 2012: Prostatický specifický antigen, metalothionein a caveolin-1 jako markery vzniku a rozvoje karcinomu prostaty. CHEMICKE LISTY 106(11), p. 1075 - 6; FULL TEXT
• ZÍTKA, O.; SKALIČKOVÁ, S.; GUMULEC, J.; MASAŘÍK, M.; ADAM, V.; HUBÁLEK, J.; TRNKOVÁ, L.; KIZEK, R., 2012: Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients. ONCOLOGY LETTERS 4(6), p. 1247 - 7, doi: 10.3892/ol.2012.931; FULL TEXT
• SZTALMACHOVÁ, M.; HLAVNA, M.; GUMULEC, J.; HOLUBOVÁ, M.; BABULA, P.; BALVAN, J.; SOCHOR, J.; TANHÄUSEROVÁ, V.; RAUDENSKÁ, M.; KŘÍŽKOVÁ, S.; ADAM, V.; ECKSCHLAGER, T.; KIZEK, R.; MASAŘÍK, M., 2012: Effect of zinc(II) ions on the expression of pro- and anti-apoptotic factors in high-grade prostate carcinoma cells. ONCOLOGY REPORTS 28(3), p. 806 - 9; FULL TEXT
• BABULA, P.; MASAŘÍK, M.; ADAM, V.; ECKSCHLAGER, T.; STIBOROVÁ, M.; TRNKOVÁ, L.; ŠKUTKOVÁ, H.; PROVAZNÍK, I.; HUBÁLEK, J.; KIZEK, R., 2012: Mammalian metallothioneins: properties and functions. METALLOMICS 4(8), p. 739 - 12, doi: 10.1039/c2mt20081c; FULL TEXT
• KŘÍŽKOVÁ, S.; VACULOVIČOVÁ, M.; HYNEK, D.; ECKSCHLAGER, T.; HODEK, P.; MASAŘÍK, M.; ADAM, V.; KIZEK, R., 2012: Immunoextraction of zinc proteins from human plasma using chicken yolk antibodies immobilized onto paramagnetic particles and their electrophoretic analysis. ELECTROPHORESIS 33(12), p. 1824 - 9, doi: 10.1002/elps.201100638; FULL TEXT
• GUMULEC, J.; MASAŘÍK, M.; KŘÍŽKOVÁ, S.; HLAVNA, M.; BABULA, P.; HRABEC, R.; ROVNÝ, A.; MASAŘÍKOVÁ, M.; SOCHOR, J.; ADAM, V.; ECKSCHLAGER, T.; KIZEK, R., 2012: Evaluation of alpha-methylacyl-CoA racemase, metallothionein and prostate specific antigen as prostate cancer prognostic markers. NEOPLASMA 59(2), p. 191 - 10, doi: 10.4149/neo_2012_025; FULL TEXT

2011

• KŘÍŽKOVÁ, S.; ZÍTKA, O.; MASAŘÍK, M.; ADAM, V.; STIBOROVÁ, M.; ECKSCHLAGER, T.; GRACE, C.; KIZEK, R., 2011: Assays for determination of matrix metalloproteinases and their activity. TRAC-TRENDS IN ANALYTICAL CHEMISTRY 30(11), p. 1819 - 14, doi: 10.1016/j.trac.2011.06.016; FULL TEXT
• MASAŘÍK, M.; GUMULEC, J.; SZTALMACHOVÁ, M.; HLAVNA, M.; BABULA, P.; KŘÍŽKOVÁ, S.; RYVOLOVÁ, M.; JURAJDA, M.; SOCHOR, J.; ADAM, V.; KIZEK, R., 2011: Isolation of metallothionein from cells derived from aggressive form of high-grade prostate carcinoma using paramagnetic antibody-modified microbeads off-line coupled with electrochemical and electrophoretic analysis. ELECTROPHORESIS 32(24), p. 3576 - 13, doi: 10.1002/elps.201100301; FULL TEXT
• GUMULEC, J.; MASAŘÍK, M.; KŘÍŽKOVÁ, S.; ADAM, V.; HUBÁLEK, J.; HRABĚTA, J.; ECKSCHLAGER, T.; STIBOROVÁ, M.; KIZEK, R., 2011: Insight to Physiology and Pathology of Zinc(II) Ions and Their Actions in Breast and Prostate Carcinoma. CURRENT MEDICINAL CHEMISTRY 18(33), p. 5041 - 11; FULL TEXT
• ZÍTKA, O.; KŘÍŽKOVÁ, S.; KREJČOVÁ, L.; HYNEK, D.; GUMULEC, J.; MASAŘÍK, M.; SOCHOR, J.; ADAM, V.; HUBÁLEK, J.; TRNKOVÁ, L.; KIZEK, R., 2011: Microfluidic tool based on the antibodymodified paramagnetic particles for detection of 8-hydroxy-2-deoxyguanosine in urine of prostate cancer patients. ELECTROPHORESIS 32(22), p. 3207 - 14, doi: 10.1002/elps.201100430; FULL TEXT

• Nano-Electro-Bio-Tools for Biochemical and Molecularly-Biological Studies of Eukaryotic Cells (NanoBioTECell) (GAP102/11/1068), Czech Science Foundation - Standard Grants, 2011 - 2015
• International Cooperation in the Field of Nanotechnologies with In Vivo Imaging Techniques (CZ.1.07/2.3.00/20.0148), MEYS - OP Education for Competiteveness, 2012 - 2014
• Study of contribution of different DNA-damaging mechanisms to toxicity of cytostatics to human chemosensitive and chemoresistant neuroblastomas (GAP301/10/0356), Czech Science Foundation - Standard Grants, 2010 - 2014
• Support of the development of high-quality teams in R&D in the field of material science (CZ.1.07/2.3.00/20.0029), MEYS - OP Education for Competiteveness, 2011 - 2014
• Partner Network for Bionanotechnological and Metallomic Research (CZ.1.07/2.4.00/31.0023), MEYS - OP Education for Competiteveness, 2012 - 2014
• New design and exploiting nanobiosensors and nanosensors to target medicine (KAN208130801), Academy of Sciences of the Czech Republic - Nanotechnologies for Society, 2008 - 2012